Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Substantiation for Dietary Supplement Claims Made Under the Federal Food, Drug, and Cosmetic Act, 64338 [E8-25791]
Download as PDF
64338
Federal Register / Vol. 73, No. 210 / Wednesday, October 29, 2008 / Notices
ANNUAL BURDEN ESTIMATES
Number of
responses per
respondent
Number of
respondents
Instrument
Average
burden hours
per
response
Total burden
hours
Help America Vote Act (HAVA) Voting Access Annual Report ......................
Help America Vote Act (HAVA) Voting Access Application ............................
50
55
1
1
24
50
1,200
2,750
Estimated Total Annual Burden Hours .....................................................
........................
........................
........................
3,950
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Dated: October 24, 2008.
Janean Chambers,
Reports Clearance Officer.
[FR Doc. E8–25752 Filed 10–28–08; 8:45 am]
jlentini on PROD1PC65 with NOTICES
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Food and Drug Administration
[Docket No. FDA–2008–D–0030] (formerly
Docket No. 2004D–0466)
[Docket No. FDA–2008–N–0543]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Substantiation for Dietary Supplement
Claims Made Under the Federal Food,
Drug, and Cosmetic Act
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Waiver of In Vivo
Demonstration of Bioequivalence of
Animal Drugs in Soluble Powder Oral
Dosage Form Products and Type A
Medicated Articles
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
ACTION:
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Substantiation for Dietary Supplement
Claims Made Under the Federal Food,
Drug, and Cosmetic Act’’ has been
approved by the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of Information
Management (HFA–710), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–796–3794.
SUPPLEMENTARY INFORMATION: In the
Federal Register of April 25, 2008 (73
FR 22423), the agency announced that
the proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0626. The
approval expires on August 31, 2011. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.reginfo.gov/
public/do/PRAMain.
BILLING CODE 4160–01–S
17:17 Oct 28, 2008
Jkt 217001
PO 00000
Food and Drug Administration,
HHS.
Dated: October 22, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–25791 Filed 10–28–08; 8:45 am]
VerDate Aug<31>2005
AGENCY:
Frm 00038
Fmt 4703
Sfmt 4703
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the waiver requirement procedures that
are recommended by the agency for in
vivo demonstration of bioequivalence
for generic soluble powder oral dosage
form products and Type A medicated
articles.
Submit written or electronic
comments on the collection of
information by December 29, 2008.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane,
rm.1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of Information
Management (HFA–710), Food and Drug
DATES:
E:\FR\FM\29OCN1.SGM
29OCN1
Agencies
[Federal Register Volume 73, Number 210 (Wednesday, October 29, 2008)]
[Notices]
[Page 64338]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-25791]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2008-D-0030] (formerly Docket No. 2004D-0466)
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Substantiation for Dietary
Supplement Claims Made Under the Federal Food, Drug, and Cosmetic Act
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Substantiation for Dietary
Supplement Claims Made Under the Federal Food, Drug, and Cosmetic Act''
has been approved by the Office of Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of
Information Management (HFA-710), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-796-3794.
SUPPLEMENTARY INFORMATION: In the Federal Register of April 25, 2008
(73 FR 22423), the agency announced that the proposed information
collection had been submitted to OMB for review and clearance under 44
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays
a currently valid OMB control number. OMB has now approved the
information collection and has assigned OMB control number 0910-0626.
The approval expires on August 31, 2011. A copy of the supporting
statement for this information collection is available on the Internet
at https://www.reginfo.gov/public/do/PRAMain.
Dated: October 22, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-25791 Filed 10-28-08; 8:45 am]
BILLING CODE 4160-01-S